Phosphoramidites & Modified Nucleoside Reagents Market
完整報告名稱與涵蓋範圍
Phosphoramidites & Modified Nucleoside Reagents Market Size, Share & Trends Analysis Report, By Product Type (Standard DNA Phosphoramidites, RNA Phosphoramidites (TBDMS, TOM and ACE), Modified and Therapeutic-Grade Amidites (2'-MOE, LNA, cEt, Phosphorothioate-Compatible), Specialty, Trimer and Labelled Amidites), By Grade (Research Grade, GMP and Therapeutic Grade), By Supply Model (Catalog Supply, Custom and Contract Amidite Manufacturing), By Application, By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The phosphoramidites and modified nucleoside reagents market covers the activated nucleoside monomers used in solid-phase oligonucleotide synthesis, including standard DNA and RNA amidites, modified and therapeutic-grade amidites such as 2'-MOE, locked and constrained ethyl nucleic acid monomers, and specialty, trimer and labelled amidites, supplied through catalog and custom manufacturing in research and GMP grades. Solid supports, labelling reagents and purification consumables are covered in adjacent InsightAce studies, and the broader oligonucleotide synthesis market is addressed separately.
Amidite demand is being pulled by commercial antisense and siRNA therapeutics that consume kilogram quantities of modified monomers per year, by the diagnostic industry's need for high-purity primers and probes and by synthetic biology and library construction. Therapeutic-grade supply requires stringent impurity control, regulatory documentation and multi-tonne capacity for phosphorothioate-compatible chemistries, which has prompted capacity investment by specialists and the entry of Chinese and Korean fine chemical producers. Buyers are diversifying sources after periods of tight supply, and price competition for standard amidites contrasts with premium pricing for proprietary modified monomers protected by patents and know-how.
North America and Europe host the reagent leaders and most therapeutic demand, while China and India have become major production centres. Competition involves nucleoside chemistry specialists, diversified life science suppliers and Asian manufacturers scaling GMP capacity.
The InsightAce study includes revenue forecasts in US$ for all product type, grade, supply model, application and end user and regional segments across 2026-2035, segment-level trend analysis, competitive positioning assessment and company profiles.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Phosphoramidites & Modified Nucleoside Reagents Market Snapshot
Chapter 4. Global Phosphoramidites & Modified Nucleoside Reagents Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. Product Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product Type:
5.2.1. Standard DNA Phosphoramidites
5.2.2. RNA Phosphoramidites (TBDMS, TOM and ACE)
5.2.3. Modified and Therapeutic-Grade Amidites (2'-MOE, LNA, cEt, Phosphorothioate-Compatible)
5.2.4. Specialty, Trimer and Labelled Amidites
Chapter 6. Market Segmentation 2: By Grade Estimates & Trend Analysis
6.1. Grade & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Grade:
6.2.1. Research Grade
6.2.2. GMP and Therapeutic Grade
Chapter 7. Market Segmentation 3: By Supply Model Estimates & Trend Analysis
7.1. Supply Model & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Supply Model:
7.2.1. Catalog Supply
7.2.2. Custom and Contract Amidite Manufacturing
Chapter 8. Market Segmentation 4: By Application Estimates & Trend Analysis
8.1. Application & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
8.2.1. Therapeutic Oligonucleotide Manufacturing
8.2.2. Diagnostic Probe and Primer Synthesis
8.2.3. Research, Library and Synthetic Biology Applications
Chapter 9. Market Segmentation 5: By End User Estimates & Trend Analysis
9.1. End User & Market Share, 2026 & 2035
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
9.2.1. Oligonucleotide Manufacturers and CDMOs
9.2.2. Diagnostic and Reagent Companies
9.2.3. Academic and Research Institutes
Chapter 10. Phosphoramidites & Modified Nucleoside Reagents Market: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. United States
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. United Kingdom
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia Pacific
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. South Korea
10.3.5. Australia
10.3.6. Southeast Asia
10.3.7. Rest of Asia Pacific
10.4. Latin America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Rest of Latin America
10.5. Middle East & Africa
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
Chapter 11. Competitive Landscape
11.1. Company Market Positioning Analysis
11.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 12. Company Profiles
12.1. Glen Research (Maravai LifeSciences)
12.2. ChemGenes Corporation
12.3. Hongene Biotech Corporation
12.4. LGC Biosearch Technologies
12.5. Merck KGaA (MilliporeSigma)
12.6. Thermo Fisher Scientific Inc.
12.7. Nitto Denko Avecia Inc.
12.8. ST Pharm Co., Ltd.
12.9. Qiagen N.V. (LNA Reagents)
12.10. Link Technologies Ltd.
12.11. Tokyo Chemical Industry Co., Ltd.
12.12. BOC Sciences
12.13. Suzhou Synthesis Chemical Co., Ltd.
12.14. Biosynth
12.15. Bachem Holding AG
圖表清單 List of Tables & Figures
Table 1. Global Phosphoramidites & Modified Nucleoside Reagents Market Revenue Forecast by Product Type, 2026-2035 (US$ Mn)
Figure 1. Global Phosphoramidites & Modified Nucleoside Reagents Market Segmentation Overview
Table 2. Global Phosphoramidites & Modified Nucleoside Reagents Market Revenue Forecast by Grade, 2026-2035 (US$ Mn)
Figure 2. Global Phosphoramidites & Modified Nucleoside Reagents Market Share by Product Type, 2026 & 2035
Table 3. Global Phosphoramidites & Modified Nucleoside Reagents Market Revenue Forecast by Supply Model, 2026-2035 (US$ Mn)
Figure 3. Modified Amidite Consumption Linked to Commercial Oligonucleotide Therapeutics, 2026-2035
Table 4. Global Phosphoramidites & Modified Nucleoside Reagents Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 4. Global Phosphoramidites & Modified Nucleoside Reagents Market Share by Grade, 2026 & 2035
Table 5. Global Phosphoramidites & Modified Nucleoside Reagents Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 5. Phosphoramidite Supply Chain and Capacity Expansion by Region
Table 6. North America Phosphoramidites & Modified Nucleoside Reagents Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific Phosphoramidites & Modified Nucleoside Reagents Growth Opportunity Analysis
Table 7. Europe Phosphoramidites & Modified Nucleoside Reagents Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Price Positioning of Standard, RNA and Proprietary Modified Amidites
Table 8. Asia Pacific Phosphoramidites & Modified Nucleoside Reagents Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key Phosphoramidites & Modified Nucleoside Reagents Market Participants
Table 9. Latin America Phosphoramidites & Modified Nucleoside Reagents Market Revenue by Country, 2026-2035 (US$ Mn)
Table 10. Middle East & Africa Phosphoramidites & Modified Nucleoside Reagents Market Revenue by Country, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們